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The dichloromethane (DCM) extract of Andrographis paniculata Nees was tested for cardiovascular activity. The extract
significantly reduced coronary perfusion pressure by up to 24.5 ± 3.0mmHg at a 3mg dose and also reduced heart rate by
up to 49.5 ± 11.4 beats/minute at this dose. Five labdane diterpenes, 14-deoxy-12-hydroxyandrographolide (1), 14-deoxy-11,12-
didehydroandrographolide (2), 14-deoxyandrographolide (3), andrographolide (4), and neoandrographolide (5), were isolated
from the aerial parts of this medicinal plant. Bioassay-guided studies using animal model showed that compounds, (2) and (3)
were responsible for the coronary vasodilatation. This study also showed that andrographolide (4), the major labdane diterpene in
this plant, has minimal eﬀects on the heart.
1. Introduction
Andrographis paniculata Nees, family Acanthaceae, has been
used since time immemorial in Ayurvedic medicine, mainly
for liver problems and dysentery [1]. The plant is also known
as “Indian Echinacea” and “King of bitter.” Phytochemical
screening on this herbal plant showed that it contains a lot of
flavonoids and terpenoids while moderate in alkaloids and
tannins compounds [2]. This plant has been featured in at
least 26 Ayurvedic formulae, whereas in traditional chinese
medicine, A. paniculata is an important “cold property”.
In Malaysia, A. paniculata is more commonly known as
“hempedu bumi” and is widely used in traditional medicine,
especially for the treatment of cardiovascular disorders.
Previous researches have shown thatA. paniculata extract
and its labdane diterpenes have a broad range of pharma-
cological eﬀects such as the ability to inhibit replication of
the HIV virus [3, 4], prevent common cold [5–7], antima-
larial [8], prevent diarrhea [9], antibacterial [10], anti-
inflammatory [11–13], antihyperglycemic eﬀect [14, 15],
suppress various cancer cells [16–18], and antifertility and
pregnancy-terminating eﬀects [19].
In earlier cardiovascular studies, A. paniculata extracts
significantly reduced atherosclerotic artery stenosis and
lowered restenosis rates after angioplasty in rabbits [20]
decreases platelet aggregation in vitro [21] and were reported
to be antihypertensive in rats [22]. Nevertheless, the scientific
basis for the use of A. paniculata in treating “heart problems”
is still unclear. To our knowledge, its direct eﬀects on
the isolated heart of an animal model are not known.
Therefore, in this study, the dichloromethane (DCM) ex-
tract of A. paniculata was tested against coronary vessels,
cardiac muscle contractility, and heart rate in Langen-
dorﬀ perfused rat hearts. Our preliminary study showed
that the dichloromethane extract caused coronary vasodi-
lation, reduced heart rate while not aﬀecting the cardiac
contractility of isolated perfused rat hearts. Further isolation
work was performed on the dichloromethane extract in
order to identify the active compound(s) responsible for the
cardiovascular activity observed.
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2. Materials and Method
2.1. General. All spectral data were obtained on various
instruments; infrared (IR) spectrum was recorded on the
Perkin Elmer FT-IR (fourier transform) spectrometer RX1,
ultraviolet (UV) spectrum was taken on a Shimadzu
UV-160A UV-visible recording spectrophotometer, nuclear
magnetic resonance spectrum (NMR) was obtained from
JEOL JNM-LA400 FT-NMR spectrometer (400MHz), and
mass spectrum (MS) was recorded on a Shimadzu GC-
MS (gas chromatograph—mass spectrometry) spectrometer
(HP 6890 Series Mass Selective Detector and HP 6890 Series
GC System). The cardiovascular activity was measured using
polygraphmodel 7DGrass, peristaltic pumpmodel Compact
Drive MasterFlex, and pressure transducer model GOULD
Statham USA.
2.2. Plant Material. The aerial parts of Andrographis panic-
ulata were supplied by the Herbarium Unit, Department of
Botany, University of Malaya, with herbarium series number
KL4930.
2.3. Extraction and Isolation. Dried and ground aerial parts
(650.0 g) of the plant were extracted with dichloromethane
for 6 h using a Soxhlet apparatus at 45◦C. The extract
was concentrated under reduced pressure to yield 26.5 g
of dichloromethane (DCM) crude extract. DCM (3 g) was
chromatographed on a silica gel column with a CH2Cl2-
MeOH gradient solvent system to give 80 fractions, which
were combined into 4 subfractions (A–D) based on TLC
(thin-layer chromatography) patterns and 1H NMR spec-
tra. Subfraction B was subjected to column chromatog-
raphy on silica gel and gave 14-deoxy-11,12-dihydroan-
drographolide (2) (264.6mg, CH2Cl2/MeOH, 98 : 2) and
14-deoxyandrographolide (3) (352.8mg, CH2Cl2/MeOH,
99 : 1). Subfractions A, C, and D underwent further isolation
by column chromatography analyses over silica gel. Sub frac-
tion C gave andrographolide (4) (882.3mg, CH2Cl2/MeOH,
96 : 4), sub fraction D gave neoandrographolide (5) (44.1mg,
CH2Cl2/MeOH, 90 : 10), and sub fraction A gave 14-deoxy-
12- hydroxyandrographolide (1) (176.4mg, CH2Cl2/MeOH,
97 : 3). The structure of each compound was confirmed by
comparison of its NMR, IR, UV, and MS data with literature
values [12].
2.4. Cardiovascular Activity on Isolated Rat Hearts. The
extracts and isolated compounds were screened for their
cardiovascular eﬀects in isolated perfused rat hearts by using
the Langendorﬀ-perfused model and method, with modi-
fication [23]. The Polygraph model (Grass Instrument Co.
model 7D) was calibrated to measure heart rate, developed
tension, and coronary perfusion pressure of the heart. The
modified Krebs-Henseleit solution (37◦C) was pumped to
flow at a constant rate (10mL/min) by using a peristaltic
pump (Compact Drive Masterflex), and the gas (95% O2
and 5% CO2) was allowed to pass through this solution.
The Krebs-Henseleit solution contained the following: NaCl
118mM,D-glucose 11.6mM,NaHCO3 25mM, KCl 4.7mM,
KH2PO4 1.2mM, MgSO4 1.2mM, and CaCl2 1.23mM.
Sprague Dawley rats (250–300 g) were anaesthetized with
sodium pentobarbitone (72mg/1000 g) and killed by cervical
dislocation. The heart was isolated and put in a Petri
dish containing cold Krebs-Henseleit solution to stop the
heartbeat. After the fat and connective tissues had been
removed from the heart, the aorta was cannulated and
perfused with the Krebs-Henseleit solution. The coronary
vessel tone was indicated by coronary perfusion pressure,
which was measured with a pressure transducer (GOULD
Statham USA) and monitored with the Grass Model 7D
Polygraph.
The apex of the left ventricle was then attached with a
hook and connected to the isometric tension transducer with
a piece of thread, which passed through a pulley system. The
resting heart tension was adjusted to 2 g to the optimum
contractile force. The contractility was monitored by an
isometric tension transducer and recorded as developed
tension. Heart rate was also detected through this transducer.
The perfused isolated rat heart (PIH) was stabilised for
about 20min before any drug samples were injected. All
injections were made at the rubber tubing near the cannula
into the Krebs-Henseleit buﬀer. The labdane diterpenes com-
pounds of A. paniculata were prepared as 1mg/mL solutions.
The first compound at 100 μL was injected into the PIH
soon after its heart rate, contractility, and coronary perfusion
pressure stabilized. The eﬀect of the first compound/dose was
allowed to disappear, and then administered with the second
compound until the last compound followed by 40% ethanol
as a vehicle control and finally 1000 nmoles isoprenaline and
sodium nitroprusside as positive controls, all in the same
heart. The compounds administred to the next heart were
arranged randomly in order to avoid bias.
2.5. Statistical Analyses. Data obtained were expressed as
mean standard error (± S.E.M.). The data were analyzed
for statistical significance using Student’s t-test. P values less
than 0.05 were considered to be significant (∗P < 0.05;
∗∗P < 0.01; ∗∗∗P < 0.001).
3. Results and Discussion
The DCM extract of A. paniculata [24] significantly reduced
the coronary perfusion pressure by up to 24.5 ± 3.0 (P <
0.05) and 29.4 ± 8.5mmHg (P < 0.05) at doses of
3mg and 1mg, respectively, and the heart rate by up
to 49.5 ± 11.4 beats/minute (P < 0.05) at the 3mg
dosage. Four isolated rat hearts were used to investigate the
eﬀect of the DCM. Further isolation work was performed
on the dichloromethane extract in order to identify the
compound(s) responsible for the cardiovascular activity.
Fractionation and purification of the DCM extract led to
the isolation and purification of five labdane diterpenes,
identified as 14-deoxy-12-hydroxyandrographolide (1), 14-
deoxy-11,12-dihydroandrographolide (2) (trans isomer), 14-
deoxyandrographolide (3), andrographolide (4), and neoan-
drographolide (5) (Figure 1). The structure of each com-
pound was identified by comparison of their NMR, IR, UV,
and MS data with literature values [25]. At least seven rat
hearts were used to investigate the eﬀect of each diterpenoid
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Figure 1: Chemical structure of compounds 1–5.
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Figure 2: The eﬀects of diterpenoids isolated from the dichloromethane extract of A. paniculata, sodium nitroprusside (SNP), and 40%
EtOH, on coronary perfusion pressure of isolated rat hearts. The results are expressed as mean ± s.e.m., ∗P < 0.05, student’s paired t-test,
compounds versus vehicle (40% ethanol), n = 7. Basal coronary perfusion pressure = 72.1± 5.6mm Hg.
on coronary perfusion pressure (a measure of coronary
tone), developed tension (a measure of cardiac contractility),
and heart rate.
All compounds were prepared as 1mg/mL solutions
in 40% ethanol. The dose used for each compound was
0.1mg. All of these diterpenoids reduced coronary perfusion
pressure (CPP) significantly with compound 3 showing the
largest reduction (−19.5 ± 7.0mmHg, P < 0.05) (Figure 2).
This value was comparable with sodium nitroprusside (pos-
itive control), which reduced CPP by 22.0± 5.4mmHg (P <
0.05). The combination of all five diterpenoids in the same
amounts reduced CPP by 10.8 ± 3.7mmHg (P < 0.05).
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Figure 3: The eﬀects of diterpenoids isolated from the dichloro-
methane extract of A. paniculata, 40% EtOH and isoprenaline on
developed tension of isolated rat hearts. The results are expressed as
mean ± s.e.m, n = 7. Basal developed tension = 3.9± 0.3 g.
None of the five diterpenoids showed any significant eﬀect
on cardiac contractility and heart rate as compared with the
positive control, isoprenaline (Figures 3 and 4).
Many studies have been reported on the cardiovascular
activity of A. paniculata [20–28] and on other pharmacolog-
ical aspects [3–19]. However, no cardiovascular activity study
involving a direct eﬀect on the isolated hearts of rats has been
published previously. In this current study, the DCM crude
extract showed potent cardiovascular activity on the isolated
perfused rat heart, except that it did not aﬀect cardiac
contractility. Fractionation and purification of the DCM
extract led to the isolation of five active compounds (1–5),
with 14-deoxy-11,12-dihydroandrographolide (2) and 14-
deoxyandrographolide (3) showing the largest reduction in
coronary perfusion pressure (−18.96 ± 6.19 and −19.5 ±
7.00Mm Hg, resp.) (P < 0.05). The results from our
study support the previous finding by Zhang and Tan [26]
that showed 14-deoxy-11,12-dihydroandrographolide (2)
and 14-deoxyandrographolide (3) caused significant falls in
mean arterial pressure (MAP) in the hearts of anaesthetized
rats. However, none of the five diterpenes showed any
significant eﬀect on heart rate. This observation suggests that
compound/s other than compounds 1–5 may be responsible
for this activity.
The decreased coronary perfusion pressure is a measure-
ment for coronary artery vasorelaxation of an isolated rat
heart. Due to the constant perfusion of Krebs-Henseleit into
the heart during the experiment, any change in coronary
perfusion pressure therefore would reflect change in vascular
resistance [28]. Activation of β-adrenoceptors caused vasore-
laxation of coronary channel.
Another mechanism involved in the cardiovascular activ-
ity of 14-deoxy-11,12-dihydroandrographolide (2) and 14-
deoxyandrographolide (3) has been reported [22–24, 26].
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Figure 4: The eﬀects of diterpenoids isolated from the dichloro-
methane extract of A. paniculata, 40% EtOH and isoprenaline on
heart rate (beats/min) of isolated rat hearts. The results are
expressed as mean ± s.e.m, n = 7. Basal heart rate = 251 ±
13 beats/min.
The ability of A. paniculata extract to dilate coronary vessels
has not been reported before, but both 14-deoxy-11,12-
dihydroandrographolide (2) and 14-deoxyandrographolide
(3) have been reported to dilate aortic rings [26]. The com-
pound 14-deoxy-11,12-dihydroandrographolide (2) exhib-
ited hypotensive eﬀect in anaesthetized rats [29]. Both
compounds exert their vasorelaxant activity by the release
of nitric oxide (NO) and activation of the guanylate cyclase
pathway, as well as the blockade of Ca2+ influx through both
voltage- and receptor-operated Ca2+ channels [30].
4. Conclusions
In conclusion, the ability of 14-deoxy-11,12-dihydroandro-
grapholide (2) and 14-deoxyandrographolide (3) to dilate
coronary vessels and aortic rings [23] supports the tradi-
tional use of A. paniculata in the treatment of cardiovascular
disorder and also in alleviating hypertension. These results
also suggest that both compounds (2) and (3) might be good
drug candidates for the treatment of angina and hyperten-
sion. Therefore, further in vivo pharmacological, pharma-
cokinetic, and toxicological studies need to be undertaken.
This result also shows that the major compound, andro-
grapholide (4), is not the major contributor to the cardi-
ovascular activity of this plant.
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